Sharps Technology (STSS) Short Interest Ratio & Short Volume

Short interest is the volume of Sharps Technology shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 133,200 shares of STSS short. 12.93% of Sharps Technology's shares are currently sold short. Learn More on Sharps Technology's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.93% of Sharps Technology's floating shares are currently sold short.

Sharps Technology saw a decline in short interest in June. As of June 30th, there was short interest totaling 133,200 shares, a decline of 3.2% from the previous total of 137,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Sharps Technology currently has issued a total of 1,020,000 shares. Some of Sharps Technology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sharps Technology currently has a public float of 1,030,000 shares.

12.93% of Sharps Technology's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Sharps Technology: Allurion Technologies, Inc. (2.72%), CollPlant Biotechnologies Ltd. Sponsored ADR (0.88%), Retractable Technologies, Inc. (0.19%), NexGel, Inc. (1.02%), NeurAxis, Inc. (0.43%), Nexalin Technology, Inc. (0.60%), Inspira Technologies OXY B.H.N. Ltd. (1.95%), Plus Therapeutics, Inc. (11.70%), IRIDEX Corporation (2.63%), Meihua International Medical Technologies Co., Ltd. (0.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

Short selling STSS is an investing strategy that aims to generate trading profit from Sharps Technology as its price is falling. STSS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sharps Technology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of STSS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STSS, twice per month. The most recent reporting period available is June, 30 2025.